COGT
Price
$7.92
Change
+$0.08 (+1.02%)
Updated
May 21 closing price
83 days until earnings call
EFTR
Price
$1.79
Change
-$0.08 (-4.28%)
Updated
May 21 closing price
Ad is loading...

COGT vs EFTR

Header iconCOGT vs EFTR Comparison
Open Charts COGT vs EFTRBanner chart's image
Cogent Biosciences
Price$7.92
Change+$0.08 (+1.02%)
Volume$738.12K
CapitalizationN/A
eFFECTOR Therapeutics
Price$1.79
Change-$0.08 (-4.28%)
Volume$55.02K
CapitalizationN/A
View a ticker or compare two or three
COGT vs EFTR Comparison Chart

Loading...

COGTDaily Signal changed days agoGain/Loss if shorted
 
Show more...
EFTRDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
COGT vs. EFTR commentary
May 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COGT is a Hold and EFTR is a Hold.

COMPARISON
Comparison
May 22, 2024
Stock price -- (COGT: $7.84 vs. EFTR: $1.87)
Brand notoriety: COGT and EFTR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: COGT: 51% vs. EFTR: 26%
Market capitalization -- COGT: $711.36M vs. EFTR: $8.8M
COGT [@Biotechnology] is valued at $711.36M. EFTR’s [@Biotechnology] market capitalization is $8.8M. The market cap for tickers in the [@Biotechnology] industry ranges from $586.12B to $0. The average market capitalization across the [@Biotechnology] industry is $2.74B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COGT’s FA Score shows that 0 FA rating(s) are green whileEFTR’s FA Score has 0 green FA rating(s).

  • COGT’s FA Score: 0 green, 5 red.
  • EFTR’s FA Score: 0 green, 5 red.
According to our system of comparison, both COGT and EFTR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COGT’s TA Score shows that 7 TA indicator(s) are bullish while EFTR’s TA Score has 5 bullish TA indicator(s).

  • COGT’s TA Score: 7 bullish, 2 bearish.
  • EFTR’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, COGT is a better buy in the short-term than EFTR.

Price Growth

COGT (@Biotechnology) experienced а +6.67% price change this week, while EFTR (@Biotechnology) price change was -6.50% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.73%. For the same industry, the average monthly price growth was +6.30%, and the average quarterly price growth was +63.23%.

Reported Earning Dates

COGT is expected to report earnings on Aug 12, 2024.

EFTR is expected to report earnings on May 10, 2024.

Industries' Descriptions

@Biotechnology (+1.73% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for COGT with price predictions.
OPEN
A.I.dvisor published
a Summary for EFTR with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
COGT($750M) has a higher market cap than EFTR($8.8M). COGT YTD gains are higher at: 33.333 vs. EFTR (-83.398).
COGTEFTRCOGT / EFTR
Capitalization750M8.8M8,526%
EBITDAN/AN/A-
Gain YTD33.333-83.398-40%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
COGT: Fundamental Ratings
COGT
OUTLOOK RATING
1..100
18
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
52
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
COGTEFTR
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
89%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
84%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 2 days ago
83%
MACD
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
84%
Bearish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 2 days ago
72%
Advances
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 13 days ago
77%
Declines
ODDS (%)
Bearish Trend 5 days ago
87%
Bearish Trend 2 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
81%
N/A
Aroon
ODDS (%)
Bullish Trend 1 day ago
78%
N/A
View a ticker or compare two or three
Ad is loading...
COGTDaily Signal changed days agoGain/Loss if shorted
 
Show more...
EFTRDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VRTIX322.841.07
+0.33%
Vanguard Russell 2000 Index I
MCGIX13.19N/A
N/A
AMG Montrusco Bolton Large Cap Growth I
BAEIX27.77N/A
N/A
Sterling Capital Equity Income A
OISVX14.91-0.03
-0.20%
Optimum Small-Mid Cap Value Instl
FVLAX22.74-0.21
-0.92%
Fidelity Advisor Value Leaders A

COGT and

Correlation & Price change

A.I.dvisor indicates that over the last year, COGT has been loosely correlated with SNDX. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if COGT jumps, then SNDX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COGT
1D Price
Change %
COGT100%
+5.38%
SNDX - COGT
51%
Loosely correlated
-0.20%
BMEA - COGT
44%
Loosely correlated
+3.10%
KROS - COGT
42%
Loosely correlated
+0.17%
DSGN - COGT
39%
Loosely correlated
-0.23%
XFOR - COGT
37%
Loosely correlated
-3.04%
More

EFTR and

Correlation & Price change

A.I.dvisor indicates that over the last year, EFTR has been loosely correlated with NBSE. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if EFTR jumps, then NBSE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EFTR
1D Price
Change %
EFTR100%
-2.02%
NBSE - EFTR
42%
Loosely correlated
N/A
CRSP - EFTR
31%
Poorly correlated
+0.99%
ANNX - EFTR
29%
Poorly correlated
-0.69%
COGT - EFTR
29%
Poorly correlated
-0.40%
VYNE - EFTR
28%
Poorly correlated
+2.59%
More